PC

Papenfuss Consulting at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Papenfuss Consulting takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on the immune safety of new immunotherapies, starting with the immunology behind how they are developed and judged. It also works through an immunosafety case study, with attention to how experts communicate their findings.

OrganizationACT 2026 Attendance
PC
Papenfuss Consulting
Consultancies
Consultancy offering pathology and immunology expertise for the immunosafety assessment of immunotherapies.
Talk
Sun Nov 15
1:00pm–1:30pm
Part of Immunotherapies and Collaborative Approaches to Immunosafety Assessment (CE6)
The Immunology Behind Developing and Evaluating New Immunotherapies (CE6-1)
Immunotoxicology
Talk
Sun Nov 15
3:20pm–4:30pm
Part of Immunotherapies and Collaborative Approaches to Immunosafety Assessment (CE6)
Round Table Discussion: Scientific Perspectives and Key Communication Considerations by Scientific Experts for an Immunosafety (Case Study) Scenario (CE6-Panel)
Immunotoxicology

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Papenfuss Consulting

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction